BIO PEER ANALYSIS

Bio-Rad Laboratories Inc — metric-by-metric comparison with peers and the industry median

BIOBio-Rad Laboratories Inc

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

BIOIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	BIO	COH	PHIA	4DX	SHL	SN	Ind. Median
P/E	47.14	24.27	24.46	—	18.72●	20.73	26.82
P/B	1.16	4.32	2.08	-76.08●	2.15	2.50	2.50
EV/EBITDA	16.54	15.20	10.76	—	11.94	9.94●	15.54
P/S	3.07	3.55	1.35●	249.46	1.70	2.10	2.69

Financial Health
Metric	BIO	COH	PHIA	4DX	SHL	SN	Ind. Median
Current Ratio	3.21	2.46	1.32	6.57●	1.10	2.57	3.28
Debt/Equity	20.1%	22.1%	71.1%	-22.6%●	84.1%	62.9%	44.7%
NetDebt/EBITDA	-0.40●	0.42	2.03	0.71	3.04	1.72	0.82

Profitability
Metric	BIO	COH	PHIA	4DX	SHL	SN	Ind. Median
Net Margin	6.5%	14.6%●	5.5%	-3,684.6%	9.1%	10.1%	-5.7%
ROE	2.5%	18.1%●	8.4%	—	11.4%	12.1%	-8.6%
ROA	1.7%	12.4%●	3.6%	-264.3%	4.6%	6.1%	-6.4%
EBITDA Margin	18.1%	24.0%	15.4%	-818.8%	19.1%	25.6%●	5.2%

Growth + Dividend
Metric	BIO	COH	PHIA	4DX	SHL	SN	Ind. Median
Rev. Growth	1.9%	2.0%●	-1.9%	-26.0%	-0.3%	—	7.4%
NI Growth	—	-6.8%	160.1%●	—	0.3%	—	16.7%
Div. Yield	1.0%	3.6%●	3.5%	—	2.9%	3.5%	1.1%
Payout	46.4%	81.5%	33.8%	—	48.4%	52.8%	39.0%

Valuation
Metric	BIO	GKOS	BRKR	MASI	GMED	PODD	Ind. Median
P/E	47.14	—	—	124.05	18.96●	37.04	26.82
P/B	1.16●	12.86	3.82	12.00	2.35	8.61	2.50
EV/EBITDA	16.54	—	36.02	28.52	12.06●	20.32	15.54
P/S	3.07	15.65	2.71●	6.07	3.59	3.87	2.69

Financial Health
Metric	BIO	GKOS	BRKR	MASI	GMED	PODD	Ind. Median
Current Ratio	3.21	5.43●	1.55	2.68	4.56	2.49	3.28
Debt/Equity	20.1%	15.4%	68.2%	61.6%	2.4%●	72.8%	44.7%
NetDebt/EBITDA	-0.40	1.21	5.08	1.05	-0.58●	0.81	0.82

Profitability
Metric	BIO	GKOS	BRKR	MASI	GMED	PODD	Ind. Median
Net Margin	6.5%	-34.3%	-0.3%	4.9%	18.9%●	10.4%	-5.7%
ROE	2.5%	-26.4%	-0.5%	8.8%	13.3%	23.0%●	-8.6%
ROA	1.7%	-20.4%	-0.2%	3.9%	11.6%●	9.3%	-6.4%
EBITDA Margin	18.1%	-26.1%	8.8%	22.1%	28.4%●	19.8%	5.2%

Growth + Dividend
Metric	BIO	GKOS	BRKR	MASI	GMED	PODD	Ind. Median
Rev. Growth	1.9%	36.3%●	0.4%	-14.4%	23.5%	31.9%	7.4%
NI Growth	—	—	—	—	216.2%●	-24.7%	16.7%
Div. Yield	1.0%●	—	0.3%	—	—	—	1.1%
Payout	46.4%	—	-377.6%	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.